Suicide RiskEHSSANCT04888533
Efficient, Holistic, Heuristic and Semi-structured Suicide Assessment Tool (EHSSA) - Very Accurate Prediction of Risk.
An observational study of Suicide Risk, run by Care Plus NJ, Inc. at 1 site in United States.
Trial summary
Many studies have found that insights regarding suicide risk-factors for cohorts does not translate to practical value in the identification of such risk in specific individuals. E.H.S.S.A. - a suicide assessment tool that was empirically designed by an emergency psychiatry department (P.E.S.P. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Suicide Risk
- What is being tested?
- EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment Tool
- How many people
- 1,505 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Aug 2019to 31 Jan 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All patients of any age/gender/economic class with or without dementia or substance use disorders who presented to the psychiatric emergency program (P.E.S.P.- Psychiatric Emergency Screening Program of Bergen County) in psychiatric distress/crisis during a discreet 6 month period.
Who may be able to join
- Patients of any age/gender/economic class with or without dementia and/or substance use disorders
- All patients presenting to P.E.S.P.(Psychiatric Emergency Screening Program of Bergen County) in psychiatric distress/crisis.
Who cannot join
- Active Delirium.
Trial locations and contacts
1 site in 1 country.
United States1 site
Care Plus NJ, Inc.- PESP (Psychiatric Emergency Screening Program)
Paramus, New Jersey, 07652
About this study
Official title: Predicting Suicide: E.H.S.S.A. - An Efficient, Holistic, Heuristic and Semi-structured Suicide Assessment Tool for Accurately Predicting, in a Specific Patient, the Risk of Suicide in the Reasonably Foreseeable Future. (EHSSA)
Many studies have found that insights regarding suicide risk-factors for cohorts does not translate to practical value in the identification of such risk in specific individuals.
E.H.S.S.A. - a suicide assessment tool that was empirically designed by an emergency psychiatry department (P.E.S.P. of Bergen County) in its effort to accurately predict, in specific patients, the risk of suicide attempts in the reasonably foreseeable future. It is of a unique paradigm that combines critical elements of holism, heuristics and semi-structured design.
Read the detailed description
Objective:
Many studies have found that insight regarding suicide risk-factors for cohorts does not translate to practical value in the identification of such risk in specific individuals.
This performance improvement study formally examined the effectiveness of "EHSSA" (efficient, holistic/heuristic semi-structured suicide-risk assessment) - an empirically derived tool designed by this emergency psychiatry department. It is a suicide assessment tool for predicting in a specific patient (as opposed to a cohort), the risk of serious suicide attempts in the reasonably foreseeable future.
Methods:
At P.E.S.P. (Psychiatric Emergency Screening Program) of Bergen County of New Jersey, a prospective performance improvement study was done on all patients (N = 1,505) that had presented with psychiatric crisis to the department over the course of a 6 month period, (of which approximately 50% had significant suicidal ideations). The only exclusionary criteria was active delirium.
Each patient was evaluated using "EHSSA" by departmentally trained mental health professionals. Patients were deemed to either require hospitalization or be safe to be discharged to the community (with appropriate outpatient referrals). Those that were discharged (N = 137) were followed up with phone calls approximately 15 days post discharge.
- Conditions
- Suicide Risk
- Being tested
- EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment Tool
- Keywords
- Suicide Risk Assessment Tool, Holistic, Heuristic, Semi-structured, Predictive Capacity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment ToolOther
Also called EHSSA
EHSSA will be used to evaluate every patient for suicide risk.
| Study group | Role | What they receive |
|---|---|---|
| All Patients evaluated by PESP during the trial period. | EHSSA tool applied to every patient in cohort. Receives: Other: EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment Tool |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate or number of completed or attempted suicide.
Reported/ascertained cases among the cohort of completed or serious suicide attempts within 15 days of EHSSA evaluation and discharge to community or until the start of treatment with an outpatient mental health professional, whichever came sooner.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 May 2021
- Study start1 Aug 2019
- Primary completion31 Jan 2020
- Study completion31 Jan 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Suicide RiskStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,505 participants (actual)
Sponsor and investigators
- Lead sponsor
- Care Plus NJ, Inc.
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Charles Kim, M.D., Principal investigator, Care Plus NJ, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04888533
- Sponsor's protocol ID
- EHSSA prospective study- PESP
- Acronym
- EHSSA
- Status last verified
- May 2021
- First submitted
- 10 May 2021
- Last updated
- 1 Jun 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 1 Jun 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Predicting Suicide: E.H.S.S.A. - An Efficient, Holistic, Heuristic and Semi-structured Suicide Assessment Tool for Accurately Predicting, in a Specific Patient, the Risk of Suicide in the Reasonably Foreseeable Future. (EHSSA)
- ClinicalTrials.gov ID
- NCT04888533
- Acronym / sponsor ID
- EHSSA / EHSSA prospective study- PESP
- Conditions
- Suicide Risk
- Keywords
- Suicide Risk Assessment Tool, Holistic, Heuristic, Semi-structured, Predictive Capacity
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,505 participants (actual)
- Lead sponsor
- Care Plus NJ, Inc.University, hospital or other
- Study start
- 1 Aug 2019 (actual)
- Primary completion
- 31 Jan 2020 (actual)
- Study completion
- 31 Jan 2020 (actual)
- First posted
- 17 May 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Many studies have found that insights regarding suicide risk-factors for cohorts does not translate to practical value in the identification of such risk in specific individuals.
E.H.S.S.A. - a suicide assessment tool that was empirically designed by an emergency psychiatry department (P.E.S.P. of Bergen County) in its effort to accurately predict, in specific patients, the risk of suicide attempts in the reasonably foreseeable future. It is of a unique paradigm that combines critical elements of holism, heuristics and semi-structured design.
Detailed description
Objective:
Many studies have found that insight regarding suicide risk-factors for cohorts does not translate to practical value in the identification of such risk in specific individuals.
This performance improvement study formally examined the effectiveness of "EHSSA" (efficient, holistic/heuristic semi-structured suicide-risk assessment) - an empirically derived tool designed by this emergency psychiatry department. It is a suicide assessment tool for predicting in a specific patient (as opposed to a cohort), the risk of serious suicide attempts in the reasonably foreseeable future.
Methods:
At P.E.S.P. (Psychiatric Emergency Screening Program) of Bergen County of New Jersey, a prospective performance improvement study was done on all patients (N = 1,505) that had presented with psychiatric crisis to the department over the course of a 6 month period, (of which approximately 50% had significant suicidal ideations). The only exclusionary criteria was active delirium.
Each patient was evaluated using "EHSSA" by departmentally trained mental health professionals. Patients were deemed to either require hospitalization or be safe to be discharged to the community (with appropriate outpatient referrals). Those that were discharged (N = 137) were followed up with phone calls approximately 15 days post discharge.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| All Patients evaluated by PESP during the trial period. | – | Other: EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment ToolEHSSA tool applied to every patient in cohort. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All patients of any age/gender/economic class with or without dementia or substance use disorders who presented to the psychiatric emergency program (P.E.S.P.- Psychiatric Emergency Screening Program of Bergen County) in psychiatric distress/crisis during a discreet 6 month period.
Key inclusion criteria (2 listed)
- Patients of any age/gender/economic class with or without dementia and/or substance use disorders
- All patients presenting to P.E.S.P.(Psychiatric Emergency Screening Program of Bergen County) in psychiatric distress/crisis.
Key exclusion criteria (1 listed)
- Active Delirium.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EHSSA- An Efficient and Holistic/Heuristic Semi-structured Suicide Assessment ToolAlso: EHSSAEHSSA will be used to evaluate every patient for suicide risk. | Other | All Patients evaluated by PESP during the trial period. |
Primary outcome
Rate or number of completed or attempted suicide.
Time frame: 6 months
Reported/ascertained cases among the cohort of completed or serious suicide attempts within 15 days of EHSSA evaluation and discharge to community or until the start of treatment with an outpatient mental health professional, whichever came sooner.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jun 2021.
- Individual participant dataSharing planned: Undecided
Related trials for Suicide Risk
Recruiting
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR), Suicidal Ideation
RecruitingObservational study
Long-term Observation of Participants With Mood Disorders
Depression, Suicide Risk
Recruiting
SAFEGUARD Level Up Study
Risk Reduction Behavior, Suicide Prevention
Recruiting
Study to Refine the Effectiveness of New Generation Therapies for Suicide
Suicide Risk, Suicide Attempt
Recruiting
Testing the Use of VA Peer Specialists to Prevent Veteran Suicide
Suicide Risk
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Charles Kim, M.D. principal investigator
Care Plus NJ, Inc.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Suicide Risk, run by Care Plus NJ, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate or number of completed or attempted suicide. (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2021; AzTrials last refreshed its copy on 31 Oct 2026.